<?xml version="1.0" encoding="UTF-8"?>
<p>Leflunomide is approved for rheumatoid arthritis and psoriatic arthritis (not in the United States). Leflunomide inhibits the synthesis of pyrimidine 
 <italic>via</italic> acting on the mitochondrial enzyme DHODH; therefore, rapidly dividing cells, especially lymphocytes, are suppressed. On the other hand, leflunomide showed antiviral activity at least for CMV, BKV, and HIV. It works by teriflunomide, the active metabolite of leflunomide, which disrupts nucleocapsid tegumentation, and thus prevents virion assembling, rather than influences the 
 <italic>de novo</italic> pyrimidine synthesis pathway.
 <sup>
  <xref rid="bibr97-1759720X20947296" ref-type="bibr">97</xref>,
  <xref rid="bibr100-1759720X20947296" ref-type="bibr">100</xref>,
  <xref rid="bibr101-1759720X20947296" ref-type="bibr">101</xref>,
  <xref rid="bibr105-1759720X20947296" ref-type="bibr">105</xref>
 </sup>
</p>
